Department of Biomaterials and Tissue Engineering, Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, 14220 Prague, 4-Krc, Czech Republic.
Department of Biomaterials and Tissue Engineering, Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, 14220 Prague, 4-Krc, Czech Republic.
Biotechnol Adv. 2018 Jul-Aug;36(4):1111-1126. doi: 10.1016/j.biotechadv.2018.03.011. Epub 2018 Mar 18.
Stem cells can be defined as units of biological organization that are responsible for the development and the regeneration of organ and tissue systems. They are able to renew their populations and to differentiate into multiple cell lineages. Therefore, these cells have great potential in advanced tissue engineering and cell therapies. When seeded on synthetic or nature-derived scaffolds in vitro, stem cells can be differentiated towards the desired phenotype by an appropriate composition, by an appropriate architecture, and by appropriate physicochemical and mechanical properties of the scaffolds, particularly if the scaffold properties are combined with a suitable composition of cell culture media, and with suitable mechanical, electrical or magnetic stimulation. For cell therapy, stem cells can be injected directly into damaged tissues and organs in vivo. Since the regenerative effect of stem cells is based mainly on the autocrine production of growth factors, immunomodulators and other bioactive molecules stored in extracellular vesicles, these structures can be isolated and used instead of cells for a novel therapeutic approach called "stem cell-based cell-free therapy". There are four main sources of stem cells, i.e. embryonic tissues, fetal tissues, adult tissues and differentiated somatic cells after they have been genetically reprogrammed, which are referred to as induced pluripotent stem cells (iPSCs). Although adult stem cells have lower potency than the other three stem cell types, i.e. they are capable of differentiating into only a limited quantity of specific cell types, these cells are able to overcome the ethical and legal issues accompanying the application of embryonic and fetal stem cells and the mutational effects associated with iPSCs. Moreover, adult stem cells can be used in autogenous form. These cells are present in practically all tissues in the organism. However, adipose tissue seems to be the most advantageous tissue from which to isolate them, because of its abundancy, its subcutaneous location, and the need for less invasive techniques. Adipose tissue-derived stem cells (ASCs) are therefore considered highly promising in present-day regenerative medicine.
干细胞可以被定义为负责器官和组织系统发育和再生的生物组织单位。它们能够更新其群体并分化为多个细胞谱系。因此,这些细胞在先进的组织工程和细胞治疗中有很大的潜力。当在体外的合成或天然衍生的支架上接种时,干细胞可以通过适当的组成、适当的结构以及支架的适当物理化学和机械特性来分化为所需的表型,特别是如果支架特性与适当的细胞培养基组成、适当的机械、电或磁刺激相结合。对于细胞治疗,可以将干细胞直接注射到体内受损的组织和器官中。由于干细胞的再生作用主要基于生长因子、免疫调节剂和其他存储在外泌体中的生物活性分子的自分泌产生,因此可以分离这些结构并将其用于一种新的治疗方法,称为“基于干细胞的无细胞治疗”。干细胞有四个主要来源,即胚胎组织、胎儿组织、成体组织和经过基因重编程的分化体细胞,后者被称为诱导多能干细胞(iPSCs)。尽管成体干细胞的效力低于其他三种干细胞类型,即它们只能分化为有限数量的特定细胞类型,但这些细胞能够克服胚胎和胎儿干细胞应用所伴随的伦理和法律问题以及与 iPSCs 相关的突变效应。此外,成体干细胞可以自体形式使用。这些细胞存在于生物体的几乎所有组织中。然而,脂肪组织似乎是从其中分离它们的最有利组织,因为它丰富、位于皮下位置,并且需要较少的侵入性技术。因此,脂肪组织来源的干细胞(ASCs)在当今的再生医学中被认为具有很高的应用前景。